Save Time, Save Resources, Save Lives.

Board of Advisors

Charles Pick

Mr. Pick is the President of seqID inc., which specializes in agricultural genomic technologies. Mr. Pick received his BSc in Immunology at University of Toronto and his MBA at Queens University (Smith School of Business).  He has over 25 years of experience in the agriculture and biotechnology industries.  He began his career in the seed industry becoming VP of Canadian turf operations at the Pickseed Companies Group before becoming head of business development for BASF’s agricultural genomics division (DNA LandMarks) for 11 years. In 2014 Mr. Pick launched seqID with the aim of bringing the latest genomic technologies and services to the agricultural sector.

 


Dr. R. Paul Schaudies

Dr. Schaudies is the CEO and co-founder of GenArraytion, a molecular diagnostics company, and an internationally recognized expert in biodefense, biotechnology and nanotechnology.  Dr. Schaudies was the science advisor to the EPA On-Scene Coordinator, and Incident Commander of the 2001 anthrax incident in Washington, DC. As a US Army Officer, he supported the United Nations as an UNSCOM inspector in Iraq. He was an AVP and Division Manager for Biological and Chemical Defense at Science Applications International Corporation for 9 years, and spent 13 years as an active duty US Army officer and retired as a Lieutenant Colonel in the USAR. Dr. Schaudies was the Program Manager for Biological and Chemical Defense Research in the Central MASINT Office at the Defense Intelligence Agency, and a Senior Researcher at the Walter Reed Army Institute of Research with over 25 peer reviewed scientific publications.


Dr. Anilrudh Venugopal

Dr. Venugopal is a board certified Infectious Diseases and Internal Medicine physician with over 15 years of clinical experience. He previously served as an Associate Professor and Medical Director of Antibiotic Stewardship for the Loyola University Health System. He has a strong research background with numerous publications and presentations on MRSA and Clostridium difficile infections. He also consults with pharmaceutical and medical device companies to assess the potential impact of their products and helps develop strategy to target and bring products to market. He currently practices medicine in the greater Los Angeles area.